XML 29 R22.htm IDEA: XBRL DOCUMENT v3.21.4
SHARE CAPITAL (Tables)
 12 Months Ended
Sep. 30, 2021
Disclosure of classes of share capital [abstract]  
Disclosure of number and weighted average exercise prices of share options [Table Text Block]
     
Number of options		       Weighted average 
exercise price		  
Balance at September 30, 2019 and May 31, 2019   -     -  
  Granted   150,000   $ 1.25  
Balance at September 30, 2020   150,000   $ 1.25  
  Granted   895,807   $ 4.29  
  Cancelled*   (20,000 ) $ 1.25  
Balance at September 30, 2021   1,025,807   $ 3.90  
Disclosure of number of issued and outstanding stock options [Table Text Block]
    Options Outstanding and Exercisable  
 
Expiry Date		   Number of
options		      
Exercisable		      
Exercise price		     Remaining life
(Years)		  
September 21, 2024   8,807     -   $ 7.64     2.98  
July 23, 2025   150,000     150,000   $ 1.25     3.81  
November 17, 2025   447,000     30,500   $ 1.25     4.13  
April 28, 2026   240,000     -   $ 7.60     4.58  
June 15, 2026   180,000     -   $ 7.60     4.71  
Disclosure of number and weighted average exercise prices of restricted share units [Table Text Block]
    Equity settled     Cash settled     Total  
Balance at September 30, 2019 and May 31, 2019   -     -     -  
Granted   380,000     -     380,000  
Balance at September 30, 2020   380,000     -     380,000  
Vested   (95,000 )   -     (95,000 )
Balance at September 30, 2021   285,000     -     285,000  
Disclosure of equity-settled restricted share units fair value inputs [Table Text Block]
    Year ended
September 30, 2020		  
Share price on grant date $ 1.25  
Forfeiture rate   0%  
Disclosure of share based payments recognized in the consolidated statements of comprehensive loss [Table Text Block]
    Year ended
September 30,
2021		     Year ended
September 30,
2020		     Period ended
September 30,
2019		  
    $     $     $  
Stock options   643,963     138,000     -  
Restricted share units - equity settled grants   236,652     23,300     -  
Total equity settled share-based compensation expense   880,615     161,300     -  
Restricted share units - cash settled grants   -     -     -  
Total share-based compensation expense   880,615     161,300     -  
Disclosure of share based payments included in the consolidated statements of comprehensive loss [Table Text Block]
    Year ended
September 30,
2021		     Year ended
September 30,
2020		     Period ended
September 30,
2019		  
    $     $     $  
Consulting fees   8,045     -     -  
Directors' compensation   136,612     -     -  
Marketing, advertising and investor relations   3,696     -     -  
Professional fees   23,126     -     -  
Research and development   709,136     161,300     -  
Total share-based compensation expense   880,615     161,300     -  
Disclosure of number and weighted average exercise prices of warrants [Table Text Block]
    Number of warrants      Weighted average
exercise price		  
Balance at September 30, 2019 and May 31, 2019   -   $ -  
  Issued   4,079,600     0.05  
Balance at September 30, 2020   4,079,600     0.05  
  Issued*   1,709,938     9.46  
  Issued - broker   132,666     7.57  
  Exercised   (1,948,000 )   0.05  
Balance at September 30, 2021   3,974,204   $ 4.35  
Disclosure of number of outstanding warrants [Table Text Block]
    Warrants Outstanding  
Expiry Date   Number of
warrants		      
Exercise price		     Remaining life
(Years)		  
July 30, 2024 (1)   2,131,600   $ 0.05     2.83  
March 17, 2024   1,709,938   $ 9.46     2.46  
March 17, 2024   132,666   $ 7.57     2.46